drugset / Trial / NCT02299947
Bloodtranfusions After Aortic Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to answer the following question: Leads a primary coagulation corrected with a single dose of fibrinogen concentrate after ascending aorta-arc reconstruction to a decrease in the number of allogenic blood transfusions, compared to placebo?
Timeline
- Start
- 2014-08-01
- Primary completion
- 2018-04-26
- Completion
- 2018-04-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fibrinogen Concentrate Human | Protein / enzyme biologic | — | — |